ImmunoCellular Therapeutics (IMUC)
OTHER OTC:IMUC
US Market
Holding IMUC?
Track your performance easily

ImmunoCellular Therapeutics (IMUC) Financial Statements

180 Followers

ImmunoCellular Therapeutics Financial Overview

ImmunoCellular Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; ImmunoCellular Therapeutics is scheduled to report earnings on August 13, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 18Mar 18Dec 17Sep 17Jun 17
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -307.09K$ -1.02M$ -431.30K$ -3.90M$ -3.62M
EBITDA$ -306.98K$ -1.02M$ -430.66K$ -3.89M$ -3.61M
Net Income Common Stockholders$ -306.70K$ -1.02M$ -1.62M$ -6.08M$ -4.05M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.85M$ 5.03M$ 6.63M$ 6.01M$ 1.81M
Total Assets$ 3.83M$ 5.16M$ 7.01M$ 6.78M$ 4.81M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -2.85M$ -5.03M$ -6.63M$ -6.01M$ -1.81M
Total Liabilities$ 401.94K$ 1.49M$ 2.36M$ 7.30M$ 7.75M
Stockholders Equity$ 3.43M$ 3.67M$ 4.65M$ -523.31K$ -2.94M
Cash Flow-
Free Cash Flow$ -2.17M$ -1.60M$ -4.93M$ -2.22M$ -3.45M
Operating Cash Flow$ -2.17M$ -1.60M$ -4.93M$ -2.22M$ -3.45M
Investing Cash Flow--$ 0.00$ 1.33K$ 0.00
Financing Cash Flow$ 0.00$ 0.00$ 5.55M$ 6.41M$ -74.60K
Currency in USD

ImmunoCellular Therapeutics Earnings and Revenue History

ImmunoCellular Therapeutics Debt to Assets

ImmunoCellular Therapeutics Cash Flow

ImmunoCellular Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis